13 studies found for:
Gangliosidoses
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Unknown † |
Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis
|
||||
| 2 | Completed |
Pyrimethamine as a Treatment for Late-Onset GM2-gangliosidosis (Tay-Sachs and Sandhoff Disease)
|
||||
| 3 | Completed |
Pharmacokinetics, Safety and Tolerability of Zavesca (Miglustat) in Patients With Infantile Onset Gangliosidosis: Single and Steady State Oral Doses
|
||||
| 4 | Recruiting |
Nervous System Degeneration in Glycosphingolipid Storage Disorders
|
||||
| 5 | Withdrawn |
A Phase I Study of Pyrimethamine in Patients With GM2 Gangliosidosis
|
||||
| 6 | Suspended |
HSCT for High Risk Inherited Inborn Errors
|
||||
| 7 |
Completed
Has Results |
Stem Cell Transplant for Inborn Errors of Metabolism
|
||||
| 8 | Recruiting |
Fetal Umbilical Cord Blood (UCB) Transplant for Lysosomal Storage Diseases
|
||||
| 9 | Suspended |
ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases
|
||||
| 10 | Recruiting |
Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
|
||||
| 11 | Active, not recruiting |
Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
|
||||
| 12 | Completed |
Diagnostic and Screening Study of Genetic Disorders
|
||||
| 13 | Recruiting |
A Natural History Study of Hexosaminidase Deficiency
|
† Indicates status has not been verified in more than two years